Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: application of a new Cochrane risk of bias tool
Bilandzic A, Fitzpatrick T, Rosella L, Henry D. PLoS Med. 2016; 13(4):e1001987.